Contemporary Oncology (Dec 2019)
The roles of M30 and M65 in the assessment of treatment response and prognosis in patients with non-small cell lung cancer, who receive neoadjuvant treatment
Abstract
No abstracts available.Keywords
Contemporary Oncology (Dec 2019)